Showing results (191-200 of 197) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 197 results.
Blood|February 25, 2006
Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancerElisabeth H Slager, M Willy Honders, Edith D van der Meijden, et al.
Blood|January 20, 2007
Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) geneCornelis A M van Bergen, Michel G D Kester, Inge Jedema, et al.
Haematologica|March 30, 2019
Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trialMonique C Minnema, Kazem Nasserinejad, Bouke Hazenberg, et al.
Blood|April 9, 2004
The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patientsGert J Ossenkoppele, Wilfried J Graveland, Pieter Sonneveld, et al.
Leukemia|October 19, 2019
Generation and infusion of multi-antigen-specific T cells to prevent complications early after T-cell depleted allogeneic stem cell transplantation-a phase I/II studyMarthe C J Roex, Peter van Balen, Lothar Germeroth, et al.
Genes, Chromosomes & Cancer|February 26, 2017
Genomic array as compared to karyotyping in myelodysplastic syndromes in a prospective clinical trialMarian J Stevens-Kroef, Daniel Olde Weghuis, Najat ElIdrissi-Zaynoun, et al.
Haematologica|September 3, 2013
Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trialChristof Scheid, Pieter Sonneveld, Ingo G H Schmidt-Wolf, et al.
Pageof 20